These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13411427)

  • 1. Calcium benzoyl PAS: report of a clinical trial.
    PHILLIPS S; LARKIN JC; SCHLENKER FS; ULRICH EW
    Am Rev Tuberc; 1957 Apr; 75(4):667-9. PubMed ID: 13411427
    [No Abstract]   [Full Text] [Related]  

  • 2. The tolerability of calcium benzoyl-PAS and calcium PAS; a double blind study.
    JEKER K; LAUENER H; REGLI J; FRIEDRICH T
    Am Rev Tuberc; 1959 Mar; 79(3):351-6. PubMed ID: 13627443
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the tolerance of orally administered PAS-calcium and benzoyl-PAS-calcium in therapy of pulmonary tuberculosis].
    JEKER K
    Schweiz Z Tuberc Pneumonol; 1958; 15(4):211-3. PubMed ID: 13602780
    [No Abstract]   [Full Text] [Related]  

  • 4. CALCIUM benzoyl PAS.
    Tubercle; 1959 Apr; 40(2):133-5. PubMed ID: 13647667
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of original cavitary pulmonary tuberculosis with capreomycin (CM) and para-aminosalicylic acid (PAS).
    Justice FK; Schwartz WS
    Ann N Y Acad Sci; 1966 Apr; 135(2):1007-10. PubMed ID: 5327998
    [No Abstract]   [Full Text] [Related]  

  • 6. [COMMENTS ON 2 CASES OF SEVERE ALLERGIC REACTION TO SODIUM PARA-AMINOSALICYLATE (PAS)].
    POP E; NICULESCU M; ZAMFIRESCU E; NEGHINA S
    Med Interna (Bucur); 1964 Dec; 16():1493-6. PubMed ID: 14305643
    [No Abstract]   [Full Text] [Related]  

  • 7. A CONTROLLED TRIAL OF ISONIAZID AND 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE COMPARED WITH ISONIAZID AND PAS AND ISONIAZID, STREPTOMYCIN AND PAS.
    OLEJNICEK M; WEBEROVA M; NOVAK M; JANCIK E
    Tubercle; 1965 Jun; 46():188-92. PubMed ID: 14327966
    [No Abstract]   [Full Text] [Related]  

  • 8. Metal chelates and antitubercular activity. III. p-Aminosalicylic acid: chelate vs. complex.
    FOYE WO; DUVALL RN
    J Am Pharm Assoc Am Pharm Assoc; 1958 Apr; 47(4):282-5. PubMed ID: 13538806
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 10. Para-aminosalicylic acid-induced hypoglycaemia in a patient with diabetic nephropathy.
    Dandona P; Greenbury E; Beckett AG
    Postgrad Med J; 1980 Feb; 56(652):135-6. PubMed ID: 7393795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stability of benzoyl-PAS and benzoyl-PAS calcium salt].
    WILLI AV
    Arzneimittelforschung; 1957 Jan; 7(1):7-10. PubMed ID: 13412564
    [No Abstract]   [Full Text] [Related]  

  • 12. [VARIATION IN THE PRICE OF PAS PREPARATIONS AND ITS EFFECT ON THE TOTAL EXPENSES OF ANTITUBERCULAR TREATMENT].
    HAAPANEN JH; PIKKOLA E
    Duodecim; 1964; 80():551-3. PubMed ID: 14169996
    [No Abstract]   [Full Text] [Related]  

  • 13. [SUPPLEMENTARY INFORMATION ON THE ANTITUBERCULAR ACTION OF PAS-PHENYLESTERS].
    MAEKAWA N; TSUKUMA S; SHIMIZU A; KAWAI M; NAKAI J; KUZE F; OZAWA A
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1964 Mar; 12():89-96. PubMed ID: 14161659
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of antitubercular agents, especially PAS, on the serum cholesterol level in pulmonary tuberculosis].
    KAGEURA K
    Nagasaki Igakkai Zasshi; 1963 Jan; 38():54-81. PubMed ID: 13958259
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of 3 antitubercular therapeutic programs comprising isoniazid with 4,4'-diisoamyloxythiocarbanilide. streptomycin and calcium-benzoyl-PAS].
    FAVEZ G; VULLIEMOZ P; BREAUD P
    Acta Tuberc Pneumol Belg; 1963; 54():103-9. PubMed ID: 14010281
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled trial of calcium B-PAS.
    LEES AW; ALLAN GW
    Br J Dis Chest; 1961 Oct; 55():185-91. PubMed ID: 14463613
    [No Abstract]   [Full Text] [Related]  

  • 17. The acceptability of potassium para-aminosalicylate.
    MARMION T
    Br J Dis Chest; 1959 Oct; 53():409-11. PubMed ID: 14421365
    [No Abstract]   [Full Text] [Related]  

  • 18. TREATMENT OF PULMONARY TUBERCULOSIS BY CAPREOMYCIN AND PAS: A SMALL PRELIMINARY TRIAL.
    CUTHBERT J; BRUCE LG
    Tubercle; 1964 Sep; 45():205-10. PubMed ID: 14227806
    [No Abstract]   [Full Text] [Related]  

  • 19. TWENTY YEARS AFTERWARD HISTORICAL NOTES ON THE DISCOVERY OF THE ANTITUBERCULOSIS EFFECT OF PARAAMINOSALICYLIC ACID (PAS) AND THE FIRST CLINICAL TRIALS.
    LEHMANN J
    Am Rev Respir Dis; 1964 Dec; 90():953-6. PubMed ID: 14233801
    [No Abstract]   [Full Text] [Related]  

  • 20. [INVESTIGATION OF ANTITUBERCULAR AGENTS. 12. ON THE EFFECT OF PAS-ALKYLESTER AND-ARYLESTER ON THE INHIBITION OF THE GROWTH OF TUBERCLE BACILLUS IN VITRO].
    TSUKUMA S; NAKANISHI M; IKEDA N; NAKAI J; YOSHIWARA N
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1963 Sep; 12():59-64. PubMed ID: 14113186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.